Year: 2017
Blood's oxygen transporter revealed as power source for aggressive pediatric cancer
| Dec 26, 2017Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.
Learn moreASH 2017: Preliminary results show gene therapy gains in SCID
| Dec 17, 2017Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.
Learn moreASH 2017: GATA3 in Ph-like acute lymphoblastic leukemia
| Dec 17, 2017Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.
Learn moreASH 2017: Learning, networking and recruiting at the annual hematology meeting
| Dec 12, 2017The annual American Society of Hematology (ASH) meeting offers St. Jude clinicians and researchers the opportunity to learn, network and recruit. Read more.
Learn moreThe St. Jude Equations: A better method of calculating kidney function
| Dec 12, 2017Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.
Learn moreASH 2017: Research on TP53 gene variations featured in first ALL session
| Dec 9, 2017Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.
Learn moreMath helps biologist calculate variance of blood progenitor cells
| Dec 7, 2017Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.
Learn moreSickle cell study on path to improving therapies for children and adults
| Dec 7, 2017The Sickle Cell Clinical Research and Intervention Program uses data to determine therapies for children and adults. Learn more.
Learn moreTrio’s award awakens effects of sleep and sleep patterns
| Nov 29, 2017Find out how poor sleep hampers treatment of young children with cancer
Learn moreBrain studies provide treatment clues in unexpected fields
| Nov 29, 2017Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.
Learn more